Development of a liquid scintillator containing a zirconium β-keto ester complex for the ZICOS experiment

AbstractA liquid scintillator containing a zirconium β-keto ester complex has been developed for the ZIrconium Complex in Organic Scintillator (ZICOS) neutrinoless double beta decay experiment. We are aiming to develop a detector which has a good energy resolution (4% at 2.5 MeV), a large light yield (60% that of BC505) and a low background rate (0.1 counts/tonne⋅year) with several tonnes of 96Zr isotope, so we have investigated the zirconium β-keto ester complexes tetrakis(isopropyl acetoacetato)zirconium and tetrakis(ethyl acetoacetato)zirconium, which have high solubility (over 10 wt.%) in anisole. We measured the performance of liquid scintillators containing these zirconium β-keto ester complexes and obtained 40% of the light yield of BC505 and energy resolution of 4.1% at 2.5 MeV assuming 40% photo coverage of the photomultiplier in the ZICOS detector. Thus we almost achieved our initial goal. Preliminary investigations indicate that tetrakis(diethyl malonato)zirconium will give us no quenching of the light yield and an energy resolution of 2.9% at 2.5 MeV. This will be a suitable complex for the ZICOS experiment, if it has a large solubility

Development of Liquid Scintillator containing a Zirconium Complex for Neutrinoless Double Beta Decay Experiment

An organic liquid scintillator containing a zirconium complex has been developed for a new neutrinoless double beta decay experiment. In order to produce a detector that has good energy resolution (4% at 2.5 MeV) and low background (0.1 counts/(tonne・year) and that can monitor tonnes of target isotope, we chose a zirconium β-diketone complex having high solubility (over 10 wt.%) in anisole. However, the absorption peak of the diketone ligand overlaps with the luminescence of anisole. Therefore, the light yield of the liquid scintillator decreases in proportion to the concentration of the complex. To avoid this problem, we synthesized a β-keto ester complex introducing -OC3H7 or -OC2H5 substituent groups in the β-diketone ligand, and a diethyl malonate complex. Those shifted the absorption peak to around 245nm and 210nm, respectively, which are shorter than the emission peak of anisole (275nm). However, the shift of the absorption peak depends on the the scintillation solvent. Therefore we have to choose an adequate solvent for the liquid scintillator. The best performance will be obtained by pure anisole scintillator containing a tetrakis diethyl malonate zirconium. We also synthesized a Zr-ODZ complex, which has a high quantum yield (30%) and good emission wavelength (425nm) with a solubility 5 wt.% in benzonitrile. However, the absorption peak of the Zr-ODZ complex was around 240 nm. Therefore, it is better to use the scintillation solvent which has shorter luminescence wavelength than that of benzonitrile

Low Frequency Ultrasonic Array Imaging using Signal Post-processing for Concrete Material

The use of ultrasonic arrays for conducting non-destructive evaluation has been drastically increased in recent years. As one of the array imaging, a post-processing beam-forming technique has been proposed that utilizes a complete set of signals of all combinations of transmission and reception elements. This approach is referred to as full matrix capture (FMC) [1]. In FMC, each array element is sequentially used as an emitter and all other array elements are used as receivers. By changing the emitting element, we obtained a set of flaw signals that was used to form the focal beam. The delay-and-sum beam reconstruction based on the post-processing was applied to imaging of internal voids and reinforced steel bars in concrete material. The reconstruction of voids and steels in concrete specimen (400mm x 400mm x 400 mm) was demonstrated using a phased array transducer in the low frequency range. In this study, the array transducer with total 16 elements and center frequency of 50 kHz was developed. The volume fraction of aggregates in concrete was 70 %, and the maximum size of the coarse aggregate was 20 mm. Figure 1 shows the reconstruction result of a slit. For on-site inspection, we introduced a graphics processing unit (GPU) computation to accelerate the post-processing of beam-forming [2]. The flaw detection time was approximately 0.15 s using Geforce GTX880M (NVIDIA)

Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth : Involvement of protein kinase C-θ activation

Associations between growth factor receptor-mediated cell signaling and cancer cell growth have been previously characterized. Receptors for prostaglandin E2, such as EP2, and EP4, play roles in cancer growth, progression and invasion. Thus, we examined the interactions between EP2/EP4- and IGF-1R-mediated cellular signaling in human pancreatic cancer cells. Selective antagonists against EP2 and EP4 abrogated IGF-1-stimulated cell growth and suppressed MEK/ERK phosphorylation. In subsequent experiments, phospho-antibody arrays indicated increased phosphorylation levels of protein kinase C-θ (PKC-θ) at the Thr538 position following the inhibition of EP2/EP4-mediated signaling. Inhibition of PKC-θ activity impaired cell viability compared with EP2/EP4-antagonized IGF-1-stimulated cells. PKC-θ kinase MAP4K3, which plays a pivotal role in PKC-θ activation, also affected growth signaling in the presence of EP2/EP4 antagonists. Administration of EP2 and EP4 antagonists significantly inhibited the growth of an orthotopic xenograft of IGF-1-secreting pancreatic cancer cells, with increased phospho-PKC-θ and decreased phospho-ERK. Clinico-pathological analyses showed that 17.4% of surgical pancreatic cancer specimens were quadruple-positive for IGF-1R, EP2 (or EP4), MAP4K3, and PKC-θ. These results indicate a novel signaling crosstalk between EP2/EP4 and IGF-1R in cancer cells, and suggest that the MAP4K3-PKC-θ axis is central and could be exploited as a molecular target for cancer therapy

Toxicological Pathology in the Rat Placenta

The placenta grows rapidly for a short period with high blood flow during pregnancy and has multifaceted functions, such as its barrier function, nutritional transport, drug metabolizing activity and endocrine action. Consequently, the placenta is a highly susceptible target organ for drug- or chemical-induced adverse effects, and many placenta-toxic agents have been reported. However, histopathological examination of the placenta is not generally performed, and the placental toxicity index is only the placental weight change in rat reproductive toxicity studies. The placental cells originate from the trophectoderm of the embryo and the endometrium of the dam, proliferate and differentiate into a variety of tissues with interaction each other according to the development sequence, resulting in formation of a placenta. Therefore, drug- or chemical-induced placental lesions show various histopathological features depending on the toxicants and the exposure period, and the pathogenesis of placental toxicity is complicated. Placental weight assessment appears not to be enough to evaluate placental toxicity, and reproductive toxicity studies should pay more attention to histopathological evaluation of placental tissue. The detailed histopathological approaches to investigation of the pathogenesis of placental toxicity are considered to provide an important tool for understanding the mechanism of teratogenicity and developmental toxicity with embryo lethality, and could benefit reproductive toxicity studies

Performance of a liquid scintillator containing a zirconium β-keto ester complex developed for the ZICOS experiment

A liquid scintillator containing a zirconium β-keto ester complex has been developed for the ZIrconium Complex in Organic Scintillator (ZICOS) neutrinoless double beta decay experiment. We are aiming to develop a detector which has a good energy resolution (4% at 2.5 MeV), a large light yield (60% that of BC505) and a low background rate (0.1 counts/tonne・year) with several tonnes of 96Zr isotope, so we have investigated the zirconium β-keto ester complexes tetrakis (isopropyl acetoacetato) zirconium and tetrakis (ethyl acetoacetato) zirconium, which have high solubility (over 10 wt.%) in anisole. We measured the performance of liquid scintillators containing these zirconium β-keto ester complexes and obtained 40% of the light yield of BC505 and energy resolution of 4.1% at 2.5 MeV assuming 40% photo coverage of the photomultiplier in the ZICOS detector. Thus we almost achieved our initial goal. Preliminary investigations indicate that tetrakis (diethyl malonato) zirconium will give us no quenching of the light yield and an energy resolution of 2.9% at 2.5 MeV. This will be a suitable complex for the ZICOS experiment, if it has a large solubility

Dynamic responses of cyclindrical lattice shell roofs under horizontal earthquake motions with arbitrary direction by shaking table test

p. 409-419This paper is intended as an investigation of the seismic response behavior of cylindrical lattice shell structures by shaking table tests. The seismic vibration tests are carried out using small scale models with shell span of 60 cm of cylindrical lattice shell roofs with substructure under horizontal motions in arbitrary direction. From the experimental results, the effects of difference of earthquake input direction and relationship between mechanical properties of roofs and substructures on response behavior of shell roofs are made clear. In addition, it is confirmed that the seismic response evaluation methods proposed in previous papers (Takeuchi et al. [1] ~ Takeuchi et al. [3]) apply to the responses subjected to earthquake motions with arbitrary direction.Kumagai, T.; Takeuchi, T.; Susuki, I.; Ogawa, T. (2009). Dynamic responses of cyclindrical lattice shell roofs under horizontal earthquake motions with arbitrary direction by shaking table test. Editorial Universitat Politècnica de València. http://hdl.handle.net/10251/653

Discrimination of Cherenkov light in Liquid Scintillator for Neutrinoless Double Beta Decay Experiment

　A liquid scintillator containing a tetrakis（isopropyl acetoacetato）zirconium has been developed for ZICOS experiment. We will use 180 tons of liquid scintillator containing 75 kg of 96Zr in the inner balloon（45 kg in fiducial volume）surrounding 64 % photo coverage of 20 inch photomultiplier. In order to reach the sensitivity ≥1027 years, we have to reduce 95 % of 208Tl decay backgrounds at least. Using Monte Carlo simulation, we could demonstrate new method using the hit pattern of PMT which received Cherenkov light, and could reduce 93 % of 208Tl background with 78 % efficiency for 0νββ signal. For the discrimination of Cherenkov light, we measured the timing pulse shape of Zr loaded liquid scintillator using FADC digitizer, and we found an inconsistent pulse shape at the rise timing with the template of scintillation. Also the event with an inconsistent pulse shape seems to have a directionality

<原著>副腎腫瘤の臨床的検討

We reviewed the records of 13 patients with adrenal masses operated on over a ten-year period to clarify clinical characteristics of adrenal tumors. Tumors were found incidentally in seven of nine patients with primary adrenal tumors (78%); however, three of these seven patients (43%) proved to have shown symptoms related to adrenal hyperfunction when re-e、raluated. Other adrenal tumors (metastatic in three patients and inflammatory in one) were found without any symptoms referable to the tumors. In nine of 13 patients (69%), tumors were discovered by computerized tomography (CT). All patients with primary tumors have been gotten free of disease postoperatively. In contrast, although all three patients with metastatic adrenal tumors underwent resection of all known disease tissue, they died of the recurrence of malignancies within 10 months. This study suggests that a number of functional adrenal tumors are possibly left undiagnosed until found incidentally, and that CT is the most powerful tool to detect adrenal tumors. Our data did not support surgical intervention in cases of metastatic adrenal tumors.副腎腫瘤の臨床的特徴を明らかにするために過去10年間に当科で手術された13例を検討した. 原発性腫瘍9例中2例は臨床症状より原発性アルドステロン症を疑われ副腎腫瘍を発見されているが, 残りの7例(78%)は偶然腫瘍が発見された, いわゆる incidentaloma であった. しかしながら, retrospective にみるとこの7例中3例(43%)で副腎機能亢進によると考えられる症状を呈していた. 転移性腫瘍3例, histoplasma による肉芽腫1例は全て無症状であった. 13例中9例(69%)はCTにより, 2例は超音波, 1例は血管造影, 1例は scintigraphy によりそれぞれ病変を発見され, CT で副腎腫瘤を指摘できなかったのは1例のみであった. 13例中11例は経腹的に, 2例 は開胸開腹で手術されたが, 術後合併症は1例に創感染を認めたのみであった. 原発性腫瘍例は全例術後再発を認めていないが, 転移性腫瘍の3例は全例, 術後10ヶ月以内に再発死した. 以上の結果は機能性副腎腫瘍でも偶然発見されるまで診断されない場合が多いことを示唆しており, 臨床症状を注意深く検討し常に副腎腫瘍の可能性を考慮にいれることが肝要であると考えられる. また, 今回の結果より CT が副腎腫瘤の診断において重要な位置を占めるものと考えられた. なお, 転移性副腎腫瘍に対する手術療法は今回の検討ではそれを積極的に支持する結果は得られず, 今後さらに検討を要する問題と思われる